54 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35397430 | Synthesis and characterization of a new Positron emission tomography probe for orexin 2 receptors neuroimaging. | 2022 Jun | 2 |
2 | 33676539 | Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model. | 2021 Mar 6 | 1 |
3 | 30679998 | Nrf2 overexpression protects against paraquat-induced A549 cell injury primarily by upregulating P-glycoprotein and reducing intracellular paraquat accumulation. | 2019 Feb | 1 |
4 | 31305009 | Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy. | 2019 Sep | 1 |
5 | 28707509 | Intestinal absorption of pallidifloside D are limited by P-glycoprotein in mice. | 2018 Jul | 1 |
6 | 29986516 | Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter. | 2018 Jul 7 | 1 |
7 | 25264342 | Effects of the inhibition of intestinal P-glycoprotein on aliskiren pharmacokinetics in cynomolgus monkeys. | 2015 Jan | 1 |
8 | 26324318 | Chronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3/Nf-κb pathway in 2,4,6-trinitrobenzene sulfonic acid-induced colitis mice. | 2015 Sep 1 | 3 |
9 | 24280122 | The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram. | 2014 Mar 15 | 2 |
10 | 24492412 | Downregulation of CYP3A and P-glycoprotein in the secondary inflammatory response of mice with dextran sulfate sodium-induced colitis and its contribution to cyclosporine A blood concentrations. | 2014 | 2 |
11 | 24980806 | Cyclosporin A affects the bioavailability of ginkgolic acids via inhibition of P-gp and BCRP. | 2014 Nov | 2 |
12 | 24011632 | Pharmacokinetic and pharmacodynamic study of Gefitinib in a mouse model of non-small-cell lung carcinoma with brain metastasis. | 2013 Nov | 1 |
13 | 22644589 | Discrepancies in the P-glycoprotein-mediated transport of (18)F-MPPF: a pharmacokinetic study in mice and non-human primates. | 2012 Sep | 1 |
14 | 22768295 | Pharmacokinetics of quinacrine efflux from mouse brain via the P-glycoprotein efflux transporter. | 2012 | 1 |
15 | 20230790 | A novel in vivo regulatory role of P-glycoprotein in alloimmunity. | 2010 Apr 9 | 3 |
16 | 20447559 | In vivo evaluation of [123I]-4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(4-iodobenzyl)piperidine, an iodinated SPECT tracer for imaging the P-gp transporter. | 2010 May | 1 |
17 | 20460505 | The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature. | 2010 Jun 1 | 4 |
18 | 18445990 | P-glycoprotein limits the brain penetration of olopatadine hydrochloride, H1-receptor antagonist. | 2008 | 1 |
19 | 17204702 | In vivo evaluation of P-glycoprotein modulation of 8 PET radioligands used clinically. | 2007 Jan | 2 |
20 | 16384676 | Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone. | 2006 Feb 17 | 1 |
21 | 16939683 | Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice. | 2006 Oct 16 | 5 |
22 | 15802827 | Limited role of P-glycoprotein in the intestinal absorption of cyclosporin A. | 2005 Apr | 5 |
23 | 15110893 | Improved penetration of docetaxel into the brain by co-administration of inhibitors of P-glycoprotein. | 2004 May | 2 |
24 | 15176436 | Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier. | 2004 Apr | 1 |
25 | 15638123 | Functional fluo-3/AM assay on P-glycoprotein transport activity in L1210/VCR cells by confocal microscopy. | 2004 Sep | 3 |
26 | 23285492 | 11C-Labeled rhodamine-123 | 2004 | 1 |
27 | 12673668 | Potentiation of domperidone-induced catalepsy by a P-glycoprotein inhibitor, cyclosporin A. | 2003 Apr | 2 |
28 | 12855665 | Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein. | 2003 Jul | 1 |
29 | 14534356 | Pumping of drugs by P-glycoprotein: a two-step process? | 2003 Dec | 3 |
30 | 11739114 | P-gp-induced modulation of regulatory volume increase occurs via PKC in mouse proximal tubule. | 2002 Jan | 1 |
31 | 11880334 | Hyperosmotic mannitol activates basolateral NHE in proximal tubule from P-glycoprotein null mice. | 2002 Apr | 1 |
32 | 12003193 | Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate. | 2002 Feb | 1 |
33 | 12069596 | Real-time monitoring of P-glycoprotein activation in living cells. | 2002 Jun 25 | 2 |
34 | 12107549 | Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells. | 2002 Jun | 2 |
35 | 12128165 | Altered drug disposition of the platelet activating factor antagonist apafant in mdr1a knockout mice. | 2002 Aug | 1 |
36 | 11212278 | In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. | 2001 Jan 15 | 1 |
37 | 11368976 | Cyclosporin A inhibits the extrusion pump function of p-glycoprotein in the inner ear of mice treated with vinblastine and doxorubicin. | 2001 May 18 | 2 |
38 | 11489261 | Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. | 2001 Aug 10 | 1 |
39 | 11718240 | Doxorubicin ototoxicity is induced in mice by combination treatment with cyclosporin A. | 2001 Oct | 5 |
40 | 10661503 | Disruption of mdr1a p-glycoprotein gene results in dysfunction of blood-inner ear barrier in mice. | 2000 Jan 3 | 2 |
41 | 11741243 | Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene. | 2000 | 1 |
42 | 10206323 | Contribution of P-glycoprotein to bunitrolol efflux across blood-brain barrier. | 1999 Mar | 1 |
43 | 10220486 | Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein. | 1999 May | 1 |
44 | 9723952 | Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography. | 1998 Aug | 2 |
45 | 9732409 | Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein. | 1998 Sep | 1 |
46 | 8620476 | Expression of P-glycoprotein, encoded by MDR 1 gene, a metabolically active efflux pump in murine mast cells. | 1996 Mar 29 | 1 |
47 | 8647944 | P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. | 1996 Jun 1 | 1 |
48 | 8949985 | The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. | 1996 Sep | 5 |
49 | 7628053 | Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833. | 1995 | 1 |
50 | 8845485 | Cardiotoxicity in the SCID mouse following administration of doxorubicin and cyclosporin A. | 1995 Dec | 1 |